NCT01103466

Brief Summary

The purpose of this study is to evaluate the performance of Atlas (new base plate) on the degree of leakage under the base plate compared to SenSura and Conform 2. Our hypothesis is that Atlas will do better than the two comparator products.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 14, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

April 4, 2013

Completed
Last Updated

April 4, 2013

Status Verified

February 1, 2013

Enrollment Period

8 months

First QC Date

April 13, 2010

Results QC Date

January 9, 2012

Last Update Submit

February 22, 2013

Conditions

Keywords

Ileostomy base plate

Outcome Measures

Primary Outcomes (1)

  • Leakage Under the Base Plate

    Area of leakage under the base plate is recorded on a circular scale going from 0 fields to 24 fields where 0 is "no leakage" and 24 is "complete leakage" under the base plate.

    At every change of base plate

Study Arms (3)

New ostomy appliance (Atlas)

ACTIVE COMPARATOR

Atlas= new base plate. Due to company confidentiality the product is just called Atlas and this is not short for any other names

Device: Atlas

SenSura

ACTIVE COMPARATOR

Commercially available ostomy appliance

Device: SenSura

Conform 2

ACTIVE COMPARATOR

Commercially available ostomy appliance

Device: Conform 2

Interventions

AtlasDEVICE

Altas base plates are tested for 14 days (minimum 4 base plates) and the degree of leakage under the baseplate is measured and compared to two other types of base plates.

Also known as: ostomy appliance
New ostomy appliance (Atlas)
SenSuraDEVICE

SenSura base plates are tested for 14 days (minimum 4 base plates) and the degree of leakage under the baseplate is measured and compared to two other types of base plates.

Also known as: ostomy appliance
SenSura
Conform 2DEVICE

Conform 2 base plates are tested for 14 days (minimum 4 base plates) and the degree of leakage under the baseplate is measured and compared to two other types of base plates.

Also known as: Ostomy appliance
Conform 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have given written Informed Consent
  • Are at least 18 years old
  • Had their ileostomy for minimum 3 months with a size between 20-40 mm
  • Have mental capacity to understand study guidelines and questionnaires
  • Are capable to changing base plate and pouches without help. The help of a caregiver is accepted.
  • Experience leakage under the base plate at least one a week
  • Are currently using a flat 2-piece base plate with mechanical coupling
  • Have been evaluated by investigator (i.e. a health care professional) to have a stoma and peristomal skin condition that is acceptable for entering the study

You may not qualify if:

  • Pregnant or breast-feeding
  • Currently suffering from peristomal skin problems where the skin is damaged or bleeding (red and broken / broken and bleeding) as clinically evaluated by the investigator.
  • Currently receiving or have within the past 2 months received radio- and/or chemotherapy
  • Currently using steroid product on peristomal skin (injections and oral treatment are accepted)
  • Currently using a convex system
  • Participating in other clinical studies or have previously participated in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev Hospital

Herlev, 2730, Denmark

Location

Results Point of Contact

Title
Dr. Lis Hentze Poulsen
Organization
Coloplast A/S

Study Officials

  • Lis H Poulsen, MD

    Coloplast A/S

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2010

First Posted

April 14, 2010

Study Start

April 1, 2010

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

April 4, 2013

Results First Posted

April 4, 2013

Record last verified: 2013-02

Locations